Recently, Maneix et al. reported that BOR reduced c-MYC protein levels via the stabilization of histone deacetylase 3 (HDAC3) and suppressed the proliferation of a c-MYC-overexpressing human myeloma cell line [31]. Here, MYC is linked to plasma cell myeloma.